Measuring and reporting adverse events in clinical trials of psychological treatments for chronic pain
- PMID: 31815914
- DOI: 10.1097/j.pain.0000000000001772
Measuring and reporting adverse events in clinical trials of psychological treatments for chronic pain
Comment in
-
"First do no harm": why don't we measure adverse events routinely in psychological treatment trials for people with chronic pain?Pain. 2020 Apr;161(4):666-667. doi: 10.1097/j.pain.0000000000001771. Pain. 2020. PMID: 31815919 No abstract available.
References
-
- Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, Group CN. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med 2017;167:40–7.
-
- Chapman SL, Jamison RN, Sanders SH. Treatment Helpfulness Questionnaire: a measure of patient satisfaction with treatment modalities provided in chronic pain management programs. PAIN 1996;68:349–61.
-
- Cherkin DC, Sherman KJ, Balderson BH, Cook AJ, Anderson ML, Hawkes RJ, Hansen KE, Turner JA. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA 2016;315:1240–9.
-
- Cruz-Almeida Y, Fillingim RB. Can quantitative sensory testing move us closer to mechanism-based pain management?. Pain Med 2014;15:61–72.
-
- Cuervo LG, Clarke M. Balancing benefits and harms in health care. BMJ 2003;327:65–6.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical